iCAD Reports Financial Results for Third Quarter Ended September 30, 2024

Stock Information for iCad Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About iCad Inc.

SABCS 2024: New Research Assesses iCAD's Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations
CORRECTION - iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024
iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024
iCAD's ProFound Detection Version 4.0 Gains FDA Clearance
iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference
iCAD to Report Third Quarter 2024 Financial Results on November 13, 2024
iCAD to Participate in the LD Micro Main Event XVII
iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.